Chemoinformaics analysis of 4-(P-HYDROXYPHENYL)-2-BUTANONE-BETA-D-GLUCOSIDE
| Molecular Weight | 326.345 | nRot | 6 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 13 |
| Exact Molecular Weight | 326.137 | nRing | 2 |
| Solubility: LogS | -1.327 | nHRing | 1 |
| Solubility: LogP | -0.685 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 47.0034 |
| nHD | 4 | BPOL | 26.4106 |
| QED | 0.551 |
| Synth | 3.381 |
| Natural Product Likeliness | 1.574 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.356 |
| HIA | 0.772 |
| CACO-2 | -5.213 |
| MDCK | 0.00025065 |
| BBB | 0.617 |
| PPB | 0.634673 |
| VDSS | 0.503 |
| FU | 0.388953 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.064 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.352 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.304 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.775 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.079 |
| CL | 1.994 |
| T12 | 0.466 |
| hERG | 0.07 |
| Ames | 0.314 |
| ROA | 0.077 |
| SkinSen | 0.049 |
| Carcinogencity | 0.82 |
| EI | 0.013 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.066 |
| Antiviral | Yes |
| Prediction | 0.777661 |